In most studies, the high EGFR expression was associated with worse clinicopathologic prognostic parameters [28,29], as it was observed in the head and neck tumors, breast, lung and bladder cancer [4,30]. The gene discussed is EGFR; the disease is urinary bladder carcinoma.